Michael Aschner

Elsevier Recognizes Alzheimer's - Brain Awareness Month with New Book, 'A Roadmap for Curing Cancer, Alzheimer's, and Cardiovascular Disease'

Elsevier Announces NUTRACEUTICALS

CAMBRIDGE, MA - Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced the publication of Nutraceuticals: Efficacy, Safety and Toxicity, a first-of-its-kind reference detailing the use and potential toxic effects of nutraceuticals and dietary supplements. Elsevier also introduced the second edition of Drug-Like Properties: Concepts, Structure Design and Methods from ADME to Toxicity Optimization, its comprehensive and valuable working handbook on all aspects of drug research, discovery, design, development and optimization for scientists and students.